Ebselen Shows Promise Against Killer Virus

摘要

Since appearing in late 2019, the SARS-CoV-2 virus has caused sickness and death across the globe. Researchers and scientists have been looking at multiple solutions to treat COVID-19, including repur- posing (aka off-labeling) FDA-approved pharmaceutical drugs. One such preexisting drug that offers promise as a possible treatment option is Ebselen.